Signaling networks and cell cycle control the molecular basis of cancer and other diseases / edited by J. Silvio Gutkind.

Saved in:
Bibliographic Details
Other Authors: Gutkind, J. Silvio
Format: eBook
Language:English
Published: Totowa, N.J. : Humana Press, 2000.
Series:Cancer drug discovery and development.
Ebsco e-book purchased.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.
This was purchased from Ebsco with a single user license.

MARC

LEADER 00000cam a2200000La 4500
001 b1936666
003 MWH
005 20140124023438.0
006 m o u
007 cr cn|
008 001113s2000 nju ob 001 0 eng d
019 |a 191037089  |a 532795259  |a 606932725  |a 607467595 
020 |a 0585310025 (electronic bk.) 
020 |a 9780585310022 (electronic bk.) 
020 |a 159259218X 
020 |a 9781592592180 
020 |z 089603710X (alk. paper) 
020 |z 9780896037106 (alk. paper) 
029 1 |a NZ1  |b 14989522 
035 |a (OCoLC)45731249 
035 |a (OCoLC)45731249  |z (OCoLC)191037089  |z (OCoLC)532795259  |z (OCoLC)606932725  |z (OCoLC)607467595 
040 |a N$T  |b eng  |c N$T  |d OCL  |d OCLCQ  |d E7B  |d HALAN  |d OCLCQ  |d TUU  |d OCLCQ  |d TNF  |d OCLCQ  |d ZCU  |d OCLCO  |d YDXCP  |d CNTRU  |d IDEBK  |d UV0  |d OCLCE  |d OCLCF 
042 |a dlr 
049 |a HCDD 
050 4 |a E-Book QP517.C45  |b S558 2000 
060 4 |a 2004 H-358 
060 4 |a QZ 206  |b S578 2000 
070 4 |a QP517.C45  |b S558 2000 
072 7 |a SCI  |x 017000  |2 bisacsh 
072 0 |a X300 
084 |a 44.47  |2 bcl 
084 |a 44.81  |2 bcl 
245 0 0 |a Signaling networks and cell cycle control  |h [electronic resource] :  |b the molecular basis of cancer and other diseases /  |c edited by J. Silvio Gutkind. 
260 |a Totowa, N.J. :  |b Humana Press,  |c 2000. 
300 |a 1 online resource (xiv, 578 p.) 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Cancer drug discovery and development 
490 1 |a Ebsco e-book purchased 
504 |a Includes bibliographical references (p. 563-567) and index. 
505 0 0 |g 1  |t Integrin Signaling /  |r Kenneth M. Yamada, Erik H.J. Danen  |g 1 --  |g 2  |t Signal Transduction Through Tyrosine Kinase Growth Factor Receptors /  |r Paolo Fedi, Stuart A. Aaronson  |g 27 --  |g 3  |t Signaling from TGF-[beta] Receptors /  |r Anita B. Roberts, Mark P. de Caestecker, Robert J. Lechleider  |g 39 --  |g 4  |t The Wnt Signal Transduction Pathway /  |r Grant D. Barish, Bart O. Williams  |g 53 --  |g 5  |t Signaling from G-Protein-Coupled Receptors to the Nucleus /  |r Shigetomo Fukuhara, Maria Julia Marinissen, Mario Chiariello, J. Silvio Gutkind  |g 83 --  |g 6  |t Proximal Events in T-Cell Activation /  |r Joanne Sloan-Lancaster, Lawrence E. Samelson  |g 99 --  |g 7  |t Signal Transduction from the High Affinity IgE Receptor /  |r Reuben P. Siraganian  |g 113 --  |g 8  |t Signaling Through Fas (CD95, APO-1) and Related Death Receptors /  |r Richard M. Siegel, David A. Martin, Felicita Hornung, Erastus C. Dudley, Lixin Zheng, Michael J. Lenardo  |g 135 --  |g 9  |t Signal Transduction to the Nucleus by MAP Kinase /  |r Roger J. Davis  |g 153 --  |g 10  |t The Regulation of MAP Kinase Pathways by MAP Kinase Phosphatases /  |r Kathleen Kelly, Yanfang Chu  |g 165 --  |g 11  |t Control of MAPK Signaling by Ste20- and Ste11-Like Kinases /  |r Gary R. Fanger, Thomas K. Schlesinger, Gary L. Johnson  |g 183 --  |g 12  |t Ras Signaling and Transformation /  |r Geoffrey J. Clark, John P. O'Bryan, Channing J. Der  |g 213 --  |g 13  |t Signaling Pathways Controlled by Rho Family GTP-Binding Proteins /  |r Marc Symons  |g 231 --  |g 14  |t PI3-Kinases: Role in Signal Transduction /  |r David A. Fruman, Lewis C. Cantley  |g 247 --  |g 15  |t PI3K-Related Kinases: Roles in Cell-Cycle Regulation and DNA Damage Responses /  |r Randal S. Tibbetts, Robert T. Abraham  |g 267 --  |g 16  |t Integrative Signaling Through c-Abl: A Tyrosine Kinase with Nuclear and Cytoplasmic Functions /  |r Jean Y.J. Wang  |g 303 --  |g 17  |t Src: A Model for Regulation of Intracellular Signaling Molecules /  |r Pamela L. Schwartzberg  |g 325 --  |g 18  |t Inhibitors of Protein Kinase C and Related Receptors for the Lipophilic Second Messenger sn-1,2-Diacylglycerol /  |r Peter M. Blumberg, Peter Acs, Dipak K. Bhattacharyya, Patricia S. Lorenzo  |g 347 --  |g 19  |t Reactive Oxygen Species in Proliferative Signaling /  |r Toren Finkel, Daniel M. Sullivan  |g 365 --  |g 20  |t Sphingolipid Metabolites in Signal Transduction /  |r Sarah Spiegel, Sheldon Milstien  |g 379 --  |g 21  |t The Jak/Stat Signaling Cascade: Its Role in the Biological Effects of Interferons /  |r Andrew C. Larner, Andrew Keightley  |g 393 --  |g 22  |t Regulation of Cell Growth and Death by p53 /  |r Kevin M. Ryan, Karen H. Vousden  |g 411 --  |g 23  |t Regulation of NF-[kappa]B Function: Novel Molecular Targets for Pharmacological Intervention /  |r Frank Mercurio, Anthony M. Manning  |g 429 --  |g 24  |t Using Protein-Interaction Domains to Manipulate Signaling Pathways /  |r Bruce J. Mayer  |g 439 --  |g 25  |t Protein Tyrosine Kinase Inhibitors as Novel Therapeutic Agents /  |r Alexander Levitzki  |g 453 --  |g 26  |t A Pharmacological Approach to the MAP Kinase Cascade /  |r David T. Dudley, Alan R. Saltiel  |g 467 --  |g 27  |t Specific Inhibitors of p38 MAP Kinase /  |r Peter R. Young  |g 483 --  |g 28  |t Farnesyltransferase Inhibitors: Anti-Ras or Anticancer Drugs? /  |r Adrienne D. Cox, Channing J. Der  |g 501 --  |g 29  |t Targeted p53 Gene Therapy-Mediated Radiosensitization and Chemosensitization /  |r Esther H. Chang, Liang Xu, Kathleen F. Pirollo  |g 519 --  |g 30  |t Treatment of p53-Deficient Cancers by Adenovirus E1B-Region Mutants: From Basic Research to the Clinic /  |r David H. Kirn  |g 537 --  |g 31  |t The Cell Cycle Inhibitor p27 as a Prognostic Marker in Human Tumors and a Novel Target for Therapeutic Intervention /  |r Michele Pagano, Katya Ravid  |g 545 --  |g 32  |t Chemical Cyclin-Dependent Kinase Inhibitors: Therapeutic Implications /  |r Edward A. Sausville, Adrian M. Senderowicz  |g 557. 
588 |a Description based on print version record. 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [S.l.] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
590 |a This was purchased from Ebsco with a single user license. 
650 0 |a Cellular signal transduction. 
650 0 |a Cell cycle. 
650 0 |a Cellular control mechanisms. 
650 0 |a Pathology, Molecular. 
655 7 |a Electronic books.  |2 local 
690 |a Electronic resources (E-books) 
700 1 |a Gutkind, J. Silvio. 
830 0 |a Cancer drug discovery and development. 
830 0 |a Ebsco e-book purchased. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=42003  |3 Click to view e-book 
907 |a .b19366668  |b 04-18-22  |c 02-07-14 
998 |a he  |b 02-07-14  |c m  |d @   |e    |f eng  |g nju  |h 0  |i 1 
938 |a ebrary  |b EBRY  |n ebr10181210 
938 |a EBSCOhost  |b EBSC  |n 42003 
938 |a YBP Library Services  |b YANK  |n 2626075 
994 |a 92  |b HCD 
902 |a Purchased Ebsco (formally NetLibrary) e-book 
903 |a EEB-NET 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i16456257  |z 02-07-14 
999 f f |i 030e8446-830b-5ff7-8187-e97dd8be4b61  |s 72005f5a-05b3-55ae-b6fb-3f1475b6fa97 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d E-resources  |e E-Book QP517.C45 S558 2000  |h Library of Congress classification  |i Elec File  |n 1